ATE249819T1 - Präparate zur äusserlichen anwendung zur behandlung von dermatosen - Google Patents

Präparate zur äusserlichen anwendung zur behandlung von dermatosen

Info

Publication number
ATE249819T1
ATE249819T1 AT96910216T AT96910216T ATE249819T1 AT E249819 T1 ATE249819 T1 AT E249819T1 AT 96910216 T AT96910216 T AT 96910216T AT 96910216 T AT96910216 T AT 96910216T AT E249819 T1 ATE249819 T1 AT E249819T1
Authority
AT
Austria
Prior art keywords
squalane
vitamin
reduced
provides
external preparation
Prior art date
Application number
AT96910216T
Other languages
English (en)
Inventor
Tatsuo Sekisui Kagaku Shimizu
Tomoko Sekisui Kagak Horiguchi
Shimamotocho
Kiyoshi Sekisui Kagak Kuriyama
Mitsuo Sekisui Kagaku K Watabe
Original Assignee
Seikisui Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP20223295A external-priority patent/JPH0952830A/ja
Priority claimed from JP7270093A external-priority patent/JPH09110696A/ja
Application filed by Seikisui Chemical Co Ltd filed Critical Seikisui Chemical Co Ltd
Application granted granted Critical
Publication of ATE249819T1 publication Critical patent/ATE249819T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
AT96910216T 1995-04-21 1996-04-22 Präparate zur äusserlichen anwendung zur behandlung von dermatosen ATE249819T1 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP9691195 1995-04-21
JP20223295A JPH0952830A (ja) 1995-08-08 1995-08-08 皮膚疾患治療用外用剤
JP7270093A JPH09110696A (ja) 1995-10-18 1995-10-18 皮膚疾患治療用外用剤
JP27008995 1995-10-18
JP27009095 1995-10-18
PCT/JP1996/001081 WO1996032933A1 (en) 1995-04-21 1996-04-22 External preparations for treating dermatoses

Publications (1)

Publication Number Publication Date
ATE249819T1 true ATE249819T1 (de) 2003-10-15

Family

ID=27525823

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96910216T ATE249819T1 (de) 1995-04-21 1996-04-22 Präparate zur äusserlichen anwendung zur behandlung von dermatosen

Country Status (9)

Country Link
US (2) US6248779B1 (de)
EP (2) EP0766960B1 (de)
KR (1) KR100387156B1 (de)
AT (1) ATE249819T1 (de)
AU (1) AU711716B2 (de)
CA (1) CA2193742A1 (de)
DE (1) DE69629989T2 (de)
ES (1) ES2206567T3 (de)
WO (1) WO1996032933A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU741085B2 (en) * 1995-04-21 2001-11-22 Sekisui Kagaku Kogyo Kabushiki Kaisha External preparations for treating dermatoses
DE60038979D1 (de) * 1999-12-28 2008-07-03 Teikoku Seiyaku Kk Wirkstoffe gegen pruritus zum äusserlichen gebrauch
AUPR549901A0 (en) * 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
ATE444756T1 (de) * 2000-11-14 2009-10-15 Vital Health Sciences Pty Ltd Zusammensetzungen umfassend komplexe von tocopherolphosphatderivaten
WO2002092066A1 (en) * 2001-05-16 2002-11-21 Aleksandr Petrovich Khokhlov Antitumor preparation devoid of side effect
WO2003011303A1 (en) 2001-07-27 2003-02-13 Vital Health Sciences Pty Ltd Dermal therapy using phosphate derivatives of electron transfer agents
US20030215487A1 (en) * 2002-05-17 2003-11-20 Il Yang Pharm Co., Ltd. Republic Of Korea Matrix-type device for the transdermal delivery of testosterone applied to the non-scrotal skin
AU2002950713A0 (en) * 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
US6645514B1 (en) * 2002-12-19 2003-11-11 Access Business Group International, Llc Increasing skin cell renewal with water-soluble Vitamin E
ITMI20030414A1 (it) * 2003-03-06 2004-09-07 Biofarm S R L Ora Biofarmitalia S P A Tampone con strato di gel con attivita' cosmetica o terapeutica.
US7416756B2 (en) 2003-09-10 2008-08-26 Eastman Chemical Company Process for the recovery of a phytolipid composition
DK1720551T3 (da) * 2004-03-03 2011-05-16 Vital Health Sciences Pty Ltd Alkaloidformuleringer
CA2575587C (en) * 2004-08-03 2014-06-17 Vital Health Sciences Pty Ltd Carrier for enteral administration
US20090239827A1 (en) * 2005-03-03 2009-09-24 Esra Ogru Compounds having lipid lowering properties
NZ565049A (en) 2005-06-17 2012-02-24 Vital Health Sciences Pty Ltd A carrier comprising one or more DI and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
ES2999020T3 (en) 2010-02-05 2025-02-24 Phosphagenics Ltd Carrier comprising non-neutralised tocopheryl phosphate
WO2011120070A1 (en) * 2010-03-30 2011-10-06 Phosphagenics Limited Transdermal delivery patch
EP2552486B1 (de) 2010-03-30 2020-08-12 Phosphagenics Limited Pflaster für transdermale verabreichung
WO2012122586A1 (en) 2011-03-15 2012-09-20 Phosphagenics Limited New composition
CN102787074B (zh) 2011-05-20 2016-06-08 罗盖特兄弟公司 生产角鲨烯的微藻新菌株
CN102787140A (zh) * 2011-05-20 2012-11-21 罗盖特兄弟公司 从微藻制备与提取角鲨烯的工艺方法
US10420756B2 (en) 2015-03-26 2019-09-24 Sen-Jam Pharmaceutical Llc. Methods and compositions to inhibit symptoms associated with veisalgia
CN114712308A (zh) 2015-12-09 2022-07-08 磷肌酸有限公司 药物制剂
EP3558903B1 (de) 2016-12-21 2024-07-03 Avecho Biotechnology Limited Verfahren zur phosphorylierung eines komplexen alkohols

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5110113A (ja) * 1974-07-15 1976-01-27 Sumitomo Light Metal Ind Saiketsushososhikiochoseishita allznnmg keigokinoshidashizainarabinisono seizoho
JPS582922B2 (ja) 1975-02-27 1983-01-19 タカサゴコウリヨウコウギヨウ カブシキガイシヤ ハミガキノセイゾウホウ
JPS5334912A (en) 1976-09-10 1978-03-31 Yasuhisa Kitamura Skin ointment of extract from deep sea shark
US4216201A (en) * 1978-05-22 1980-08-05 Germaine Monteil Cosmetiques Corp. Cosmetic emulsion compositions having skin moisturizing properties
US4454159A (en) 1981-12-28 1984-06-12 Albert Musher Dermatological treatment preparations
JPS58183631A (ja) 1982-04-19 1983-10-26 Tanaka Yasushi アルコ−ル可溶性スクワランの製造方法
JPS5910511A (ja) 1982-07-07 1984-01-20 Eisai Co Ltd 脂溶性物質含有水性液
FR2546515B1 (fr) 1983-05-27 1986-03-28 Rhone Poulenc Sante Procede de preparation de composes carbonyles adpdiethytleniques
DE3535084A1 (de) 1985-10-02 1987-04-09 Roshdy Ismail Mittel zum schutz der haut
JPH0639380B2 (ja) 1985-10-11 1994-05-25 有限会社アイクス・ラボラトリ産業 消炎鎮痛剤組成物
JPH0667469B2 (ja) * 1986-11-17 1994-08-31 株式会社資生堂 マイクロエマルシヨン
US4847071A (en) 1987-10-22 1989-07-11 The Procter & Gamble Company Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent
JPH01290613A (ja) 1988-05-19 1989-11-22 Nissei Marine Kogyo Kk 皮膚疾患治療剤および化粧品
US4981681A (en) 1988-08-26 1991-01-01 Vittorio Tosti Lotion mixture and method of treating psoriasis
JP2998901B2 (ja) * 1990-05-08 2000-01-17 日本石油化学株式会社 熱傷治療用局所冷却剤
JP3072768B2 (ja) 1990-07-25 2000-08-07 三省製薬株式会社 色素沈着症治療剤
JPH0482834A (ja) 1990-07-25 1992-03-16 Sansho Seiyaku Co Ltd 色素沈着症治療剤
SU1751198A1 (ru) 1990-08-27 1992-07-30 Всесоюзный научно-исследовательский институт новых видов пищевых продуктов и добавок Способ производства активных сушеных дрожжей
JPH04169525A (ja) 1990-11-01 1992-06-17 Nissei Marine Kogyo Kk 血清脂質改善機能を有する組成物
JPH05269214A (ja) 1991-03-20 1993-10-19 Nendo Kagaku Kenkyusho:Kk 遠赤外線を利用する美容部材
JP2609562B2 (ja) 1991-05-27 1997-05-14 政夫 斎藤 アレルギー性皮膚炎用クリーム及びその製造方法
US5378461A (en) * 1991-07-12 1995-01-03 Neigut; Stanley J. Composition for the topical treatment of skin damage
JPH0640858A (ja) 1991-09-27 1994-02-15 Shiseido Co Ltd 養毛料
NZ244862A (en) 1991-10-23 1995-07-26 Block Drug Co Use of vitamin e in topical pharmaceuticals to enhance penetration of the active agent
JPH06179619A (ja) 1992-01-17 1994-06-28 Sekisui Chem Co Ltd 炎症性皮膚疾患治療用外用剤
JP2720246B2 (ja) 1992-06-04 1998-03-04 株式会社資生堂 皮膚外用剤
JPH06172165A (ja) 1992-12-10 1994-06-21 Sekisui Chem Co Ltd 炎症性皮膚疾患治療用外用剤
JPH06172123A (ja) 1992-12-10 1994-06-21 Mikimoto Pharmaceut Co Ltd 抗酸化剤
JPH06247852A (ja) 1993-02-22 1994-09-06 Sekisui Chem Co Ltd 炎症性皮膚疾患治療用外用剤
ES2148340T3 (es) 1993-09-01 2000-10-16 Teijin Ltd Composicion de emulsion de 1-alfa,24-(oh)2-vitamina d3.

Also Published As

Publication number Publication date
US6248779B1 (en) 2001-06-19
DE69629989D1 (de) 2003-10-23
AU5347596A (en) 1996-11-07
EP0766960B1 (de) 2003-09-17
CA2193742A1 (en) 1996-10-24
KR970703758A (ko) 1997-08-09
EP0766960A4 (de) 2000-07-12
EP1374861A1 (de) 2004-01-02
US6306898B1 (en) 2001-10-23
WO1996032933A1 (en) 1996-10-24
EP0766960A1 (de) 1997-04-09
DE69629989T2 (de) 2004-07-22
KR100387156B1 (ko) 2003-10-11
AU711716B2 (en) 1999-10-21
ES2206567T3 (es) 2004-05-16

Similar Documents

Publication Publication Date Title
ATE249819T1 (de) Präparate zur äusserlichen anwendung zur behandlung von dermatosen
DE69334294D1 (de) Antikörper für die Behandlung von einer Immunerkrankung
BR9917074A (pt) Composição cosmética ou famacêutica do tipoemulsão óleo-em-água que compreende um agentebiologicamente ativo micronizado e um sistemaemulsionante apropriado e processo detratamento cosmético
DK1289517T3 (da) Farmaceutiske sammensætninger indeholdende cannabidiolderivater
ATE207342T1 (de) Gegen hautalterung wirksame stoffe oder wirkstoffkombinationen und zubereitungen
ATE186834T1 (de) Verwendung von wirksamen mengen von aktiven stoffen zur behandlung von mischhaut
ATE62414T1 (de) Mittel zur behandlung von herzerkrankungen.
ATE183383T1 (de) Verwendung von ascorbinsäure als wirkstoff zur behandlung von seborrhoe in einer kosmetischen und/oder dermatologischen zusammensetzung
EE9900428A (et) Köhavastased ravimkoostised
IT1264530B (it) Impiego dei polisaccaridi nelle neuropatie atrofico degenerative
UA35611C2 (uk) Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри
ATE282406T1 (de) Arzneimittel und verfahren zur behandlung von intrazellulären infektionen
ATE308342T1 (de) Arzneimittel gegen diabetes-komplikationen
CA2322878A1 (en) Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
DE69705110D1 (de) Topische pharmazeutische zusammensetzungen, welche heparin enthalten
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
MX9304185A (es) Producto y composicion farmaceutica que lo contiene para el tratamiento de la mastitis y la mestritis bovina.
EP0744176A3 (de) Arzneimittel zur Hemmung von Knochenschwund
KR930019224A (ko) 유산 위험 치료제
ATE5073T1 (de) 5-amino-tetrazol-derivate von retinsaeuren, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
ATE283058T1 (de) Verwendung einer pollenextrakt-hältigen verbindung zur behandlung von dysphorie
ATE233085T1 (de) Arzneimittel zur topischen anwendung
ATE211650T1 (de) Verwendung von topische präparationen mit glyceryl trinitrat und lanolin zur behandlung von erektilen funktionsstörungen
DE69433923D1 (de) Salbe enthaltend mometason-furoat und salicylsäure zur topischen behandlung von psoriasis
DE59101818D1 (de) Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0766960

Country of ref document: EP

REN Ceased due to non-payment of the annual fee